drugset / Trial / NCT00115947

Renal and Cardiovascular Effects of Terlipressin in Patients With Cirrhosis and Ascites

NCT00115947

Phase 2/3 Completed Hvidovre University Hospital
RandomizedCrossoverDouble-blind

Summary

The purpose of this study is to investigate the effect of terlipressin on myocardial perfusion and renal function. Hypothesis: Significant improvement of renal function reflected by: glomerular filtration rate (GFR), renal blood flow (RBF), excretion of salt and metabolites in the urine and related hormones and peptides in the blood. No effect on the systolic function of the heart.

Timeline

Start
2004-12
Primary completion
Completion
2006-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Terlipressin Peptide

Indications